Increased plasma levels of soluble programmed death ligand 1 (sPD-L1) and fibroblast growth factor 23 (FGF-23) in patients with Graves’ ophthalmopathy in comparison to hyperthyroid patients without Graves’ ophthalmopathy
- Resource Type
- Article
- Source
- In
Cytokine September 2023 169 - Subject
- Language
- ISSN
- 1043-4666